Radiation Oncology · 2010 · 83 citations · 20 references
MedicineOncologyRadiation OncologyChemotherapyClinical Radiation OncologyGastrointestinal OncologyConcurrent ChemoradiationCytokines In Tumor ImmunityMucositis ManagementMucositis TreatmentRadiation TherapyGastrostomy Tube PlacementManagement Of High-risk PatientsMucositis Outcome MeasurementRadiation-induced MucositisToxicity Grading Criteria
BACKGROUND: The purpose of this pilot study was to detect a correlation between serum cytokine levels and severity of mucositis, necessitating installation of a percutaneous endoscopic gastrostomy tube (PEG) in head and neck (H&N) cancer patients receiving combined chemo-radiation therapy. PATIENTS AND METHODS: Fifteen patients with H&N epithelial cancer were recruited to this study. All patients received radiotherapy to the H&N region, with doses ranging from 50-70 Gy. Chemotherapy with cisplatin, carboplatin, 5-fluorouracil and taxanes was given to high-risk patients, using standard chemotherapy protocols. Patients were evaluated for mucositis according to WHO common toxicity criteria, and blood samples were drawn for inflammatory (IL-1, IL-6, IL-8, TNF-alpha) and anti-inflammatory (IL-10) cytokine levels before and during treatment. RESULTS: A positive correlation was found between IL-6 serum levels and severity of mucositis and dysphagia; specifically, high IL-6 levels at week 2 were correlated with a need for PEG tube installation. A seemingly contradictory correlation was found between low IL-8 serum levels and a need for a PEG tube. CONCLUSION: These preliminary results, indicating a correlation between IL-6 and IL-8 serum levels and severity of mucositis and a need for a PEG tube installation, justify a large scale study.
20
Charles A. Dinarello · The FASEB Journal · 1988 · 1.5K citations
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Zhong Chen, P. S. Malhotra, Giovana R. Thomas et al. · PubMed · 1999 · 487 citations
Life Sciences, Immunology, Oncology +17
Interleukin‐6 predicts recurrence and survival among head and neck cancer patients
Sonia A. Duffy, Jeremy M. G. Taylor, Jeffrey E. Terrell et al. · Cancer · 2008 · 332 citations · Full text
Medicine, Immunology, Oncology +15
J T Whicher, Stephen Evans · Clinical Chemistry · 1990 · 176 citations · Full text